Members of the House of Representatives have put to task the Food and Drug Administration (FDA) over the perceived delay in the approval of new drug applications, including potential medicines for the deadly COVID-19. In a recent hearing of the House Committee on Good Government and Public Accountability, lawmakers took turns grilling FDA General Manager […]
